Osteoarthritis (OA) is a painful, complex disease that affects millions of people worldwide. There is currently no disease-modifying therapy for OA, and existing drugs to treat symptoms of OA are ...
The FDA announced it planned to restrict use of GLP-1 active pharmaceutical ingredients in non-FDA-approved drugs, including those from Hims & Hers and other compounding pharmacies.